IL6 and type 2 diabetes mellitus: In the present study we show at the trend level that markers of adipocyte dysfunction such as adipocyte cell size and circulating IL-6 are further altered in FDR with manifest IGT (however, not reaching statistical significance), strengthening the concept of adipose tissue dysfunction as a contributor to the development of insulin resistance and T2D.